Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
Clinical trial NCT05140512 · COMPLETED
Trial details
- NCT number
- NCT05140512
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2021-09-15
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.